β-blockers in Heart Failure

1996 MC, R, DB (vs. placebo) U.S. Supported by Roche and GlaxoSmithKline NYHA II (53%), III (44%), IV (3%) ... Approximate Dose Equivalents of the Beta-Adrenergic Blockers Used in Patients with Chronic HF (may be used if conversion deemed appropriate) The beta-adrenergic blockers atenolol and immediate-release metoprolol tartrate (IR) have been ... ................
................